Robert Doebele

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jessica Oien, Attorney-in- Fact for Robert Doebele
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Doebele:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rain Oncology Inc. President, Chief Scientific Officer Common Stock, par value $0.001 per share 0 $0 $1.21 26 Jan 2024 Direct
Boundless Bio, Inc. Chief Medical Officer Stock Option (right to buy) 230,000 23 Jan 2026 Direct
Boundless Bio, Inc. Chief Medical Officer Stock Option 180,000 03 Feb 2025 Direct
Rain Oncology Inc. President, Chief Scientific Officer Stock Option (Right to Buy) 0 26 Jan 2024 Direct

Insider Reports Filed by Robert Doebele

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BOLD Boundless Bio, Inc. 23 Jan 2026 1 $0 4 Chief Medical Officer 26 Jan 2026, 07:00
BOLD Boundless Bio, Inc. 03 Feb 2025 1 $0 4 Chief Medical Officer 03 Feb 2025, 18:38
BOLD Boundless Bio, Inc. 03 Feb 2025 0 $0 3 Chief Medical Officer 03 Feb 2025, 18:29
/report/000199937124000958-doebele-robert-2024-01-26 Rain Oncology Inc. 26 Jan 2024 13 $0 4 President, Chief Scientific Officer 26 Jan 2024, 16:36
/report/000110465923090705-doebele-robert-2023-08-09 Rain Oncology Inc. 09 Aug 2023 2 $0 4 President, Chief Scientific Officer 11 Aug 2023, 21:16
/report/000110465923023387-doebele-robert-2023-02-15 Rain Oncology Inc. 15 Feb 2023 1 $0 4 President, Chief Scientific Officer 17 Feb 2023, 17:18
/report/000089924322025741-doebele-robert-2022-07-06 Rain Therapeutics Inc. 06 Jul 2022 2 +$15,366 4 President, Chief Scientific Officer 07 Jul 2022, 18:02
/report/000089924322014886-doebele-robert-2022-04-13 Rain Therapeutics Inc. 13 Apr 2022 2 +$11,850 4 President, Chief Scientific Officer 15 Apr 2022, 16:30
/report/000089924322013322-doebele-robert-2022-03-31 Rain Therapeutics Inc. 31 Mar 2022 2 +$7,900 4 President, Chief Scientific Officer 04 Apr 2022, 16:15
/report/000089924322004834-doebele-robert-2022-01-07 Rain Therapeutics Inc. 07 Jan 2022 1 $0 4 EVP, Chief Scientific Officer 04 Feb 2022, 15:35
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .